Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71610-036

6 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 80mg (71610 036 15)

Bottle Label 80mg (71610 036 15)
Atorvastatin Calcium 80 mg film-coated tablet label for 15 tablets. The label includes storage instructions, dispensing details, manufacturer SciGen Pharmaceuticals Inc., and repackager Aphena Pharma Solutions - Tennessee, LLC. The product is for oral use and marked RX Only.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph comparing cumulative incidence percentages over 3.5 years for Atorvastatin versus Placebo. The solid line represents Atorvastatin with a lower cumulative incidence, while the dashed line represents Placebo with a higher incidence. The graph includes hazard ratio (HR=0.64) and p-value (0.0005), indicating statistical comparison between the two groups.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line chart comparing cumulative hazard percentages over five years for placebo versus atorvastatin groups. The x-axis represents time to first primary endpoint from baseline to four years of follow-up, and the y-axis shows cumulative hazard percentage. The chart includes hazard ratio (HR) 0.63 with confidence interval and p-value.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing an event over time for Atorvastatin 10 mg and 80 mg. The x-axis represents time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event, ranging from 0 to 0.2. The graph includes hazard ratio and p-value statistics.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of Atorvastatin Calcium, showing its molecular configuration including aromatic rings, hydroxyl groups, and calcium ion association.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.